PPT-Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

Lauren Barney April 17 2013 Breast Cancer Subtypes Breast cancer is classified into clinical subtypes based upon receptor expression These subtypes dictate possible therapeutic options and vary in their prognosis. Lauren Barney. April 17, 2013. Breast Cancer Subtypes. Breast cancer is classified into clinical subtypes based upon receptor expression. These subtypes dictate possible therapeutic options and vary in their prognosis. Lauren Barney. April 17, 2013. Breast Cancer Subtypes. Breast cancer is classified into clinical subtypes based upon receptor expression. These subtypes dictate possible therapeutic options and vary in their prognosis. Jennifer M. Matro, MD. Rena Rowan Breast Center. Abramson Cancer Center. University of Pennsylvania. Overview. What is metastatic breast . c. ancer (MBC)?. Who is at risk?. Subtypes of Breast Cancer. Mohammad . Jahanzeb. , MD, FACP. Professor of Clinical Medicine, Hematology-Oncology. Director, UM Sylvester Deerfield Campus. Associate Center Director for Community Outreach. Sylvester Comprehensive Cancer Center. What’s Positive about Triple Negative Breast Cancer ? Julie R. Gralow, M.D. Jill Professor Endowed Professor of Breast Cancer Director, Breast Medical Oncology Seattle Cancer Care Alliance University of Washington School of Medicine Julie R. Gralow, M.D.. Director, Breast Medical Oncology. Jill Bennett Endowed Professor of Breast Cancer. Professor, Global Health. University of Washington School of Medicine. Fred Hutchinson Cancer Research Center. Cyllene R. Morris, DVM, PhD. California Cancer Registry. R. isk of contralateral breast cancer (BC). Estimated risk: 0.5% - 1% per year. risk in BRCA1-BRAC2 carriers, family history. risk if lobular carcinoma in situ (LCIS) (risk for invasive lobular carcinomas?). Alexis Clark. 1. . and Rebecca Haberman. 1. 1. Dept. of Biology, Mary Baldwin University, Staunton, VA. Introduction. . In the United States alone 1 in 8 women will develop invasive breast cancer over the course of their lifetime(1).. Professor of Medicine and Oncology. Karmanos Cancer Institute. Wayne State University. Breast Cancer 101. Biopsy +. Lumpectomy + RT. Mastectomy. SLNBx. ALND (> 3+ micro or macro preop and bx +). Standard, . A. University of Tennessee Medical Center – Knoxville. Departments of Pathology, Surgery, and Medicine. BREAST CANCER IN YOUNG AGE (≤40 YEARS): THE UNIVERSITY OF. . TENNESSEE MEDICAL CENTER AT KNOXVILLE 10 YEAR EXPERIENCE. Breast Cancer in the US . Breast Cancer is estimated to affect . over 230,000 . women . annually in the US. Based on SEER Database rates from 2009-2011, the . cumulative lifetime risk. of an average woman in the general US population is 12.3%. Percent with Patients. Number of Patients (Median). ER-positive, HER2-negative breast cancer for whom you ordered a genomic assay. 92. 14. Metastatic ER-positive, HER2-negative . breast cancer. 96. 10. Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhutan. Define the breast cancer. Is the cancer operable?. Stage 1: systemic therapy after surgery (and radiation if breast conservation). Stage 2: systemic therapy before or after therapy. breast. . cancer. . needs. . different. . therapeutic. . strategies. . than. HER-2 . enriched. . tumors. ?. Patrizia Vici. Cleopatra. TDM-1: . EMILIA. Verma. S ESMO 2012. (. Activity. . HR+.